On July $1,2021,$ Truman Company acquired a $70$ percent interest in Atlanta Company in exchange for consideration of $$772,275$ in cash and equity securities$.$ The remaining $30$ percent of Atlanta's shares traded closely near an average price that totaled $$330,975$ both before and after Truman's acquisition.

In reviewing its acquisition, Truman assigned a $$132,000$ fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is anticipated to have a remaining life of five years.

The following financial information is available for these two companies for $2021.$ In addition, the subsidiary's income was earned uniformly throughout the year. The subsidiary declared dividends quarterly.

a$.$ What is the excess fair$-$value assigned to patent and goodwill?

b$.$ How did Truman allocate the goodwill from the acquisition across the controlling and noncontrolling interests?

c$.$ How did Truman derive the Investment in Atlanta account balance at the end of $2021?$

d$.$ Prepare a worksheet to consolidate the financial statements of these two companies as of December $31,2021.$ At year$-$end, there$\backslash$table$[[$Revenues$,$Company,Company,,Interest,Totals,$],[$Debit$,],[$$$,(801,490),$$$,(429,000),,,],[$Operating expenses,,$454,000,,304,000,,,?,],[$Net income of subsidiary,,$(34,510),,0,,,?,P$